In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Telix Pharmaceuticals Limited is one of them. Melbourne-based Telix Pharmaceuticals Limited (NASDAQ:TLX) is advancing its global footprint in precision oncology and targeted radiotherapies, with active clinical programs in prostate cancer and rare oncologic conditions. In its 2025 half-year update, the company reported a 30% revenue increase in its Precision Medicine segment, led by strong demand for its f ...